ClinConnect ClinConnect Logo
Search / Trial NCT07042997

Ultrasound Evaluation of Blind Dry Needling in Lateral Epicondylitis

Launched by NURMUHAMMET TAS · Jun 20, 2025

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

Lateral Epicondylitis Dry Needling Trigger Point Ultrasound Guidance

ClinConnect Summary

This clinical trial is studying a treatment called dry needling for people with lateral epicondylitis, which is a type of pain on the outer part of the elbow often called “tennis elbow.” The study aims to see how accurate and consistent the dry needling procedure is when done without looking, by comparing it to a guided technique using ultrasound (a kind of imaging that lets doctors see inside the body). This helps the researchers understand if the blind needling method is done correctly and targets the right spots in the muscles.

People who might join this study are adults aged 18 to 70 who have had elbow pain for at least six weeks and have specific tender areas, called trigger points, in the muscles of their forearm. If you join, a doctor will examine your arm to find these trigger points. The study is still not recruiting participants yet, but if you take part, you can expect the dry needling procedure to be done while the researchers check its accuracy with ultrasound. Your participation will help improve how this treatment is performed and could lead to better care for people with this kind of elbow pain.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Volunteers aged 18-70 years,
  • who have pain in the lateral epicondyle region for at least 6 weeks
  • who have active trigger points in the forearm extensor muscles detected by physical examination
  • Exclusion Criteria:
  • Those who have not complained of pain in the lateral epicondyle region for at least 6 weeks

About Nurmuhammet Tas

Nurmuhammet Tas is a clinical trial sponsor engaged in advancing medical research through the design, funding, and oversight of clinical studies. Committed to scientific rigor and patient safety, the sponsor facilitates the development of innovative therapies and contributes to the generation of high-quality clinical evidence aimed at improving healthcare outcomes.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported